| MORPHOSYS AG | 124.60 / +0.56% |
| Date/Time | 12/11 / 17:29 |
| Chg. / Chg.(%) | 0.70 / +0.56% |
| Bid | 124.50 / 28 |
| Ask | 124.60 / 26 |
| Open | 124.20 |
| Previous Close | 123.90 |
| High | 124.60 |
| Low | 122.90 |
| Volume [EUR] | 1,250,189.85 |
| Volume [Units] | 10,105 |
| Price fixings | 251 |
| ISIN | DE0006632003 |
| Security | MOR/D |
| Exchange | Turquoise |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Xetra | 124.40 |  |
155,830 |
| Cboe Europe .. | 124.60 | |
18,841 |
| Cboe Europe .. | 124.60 | |
16,389 |
| London Inter.. | 123.25 | |
13,903 |
| Turquoise | 124.60 | |
10,105 |
| TradeGate | 124.500 | |
9,511 |
| Stuttgart | 124.600 | |
1,911 |
| Nasdaq Other.. | 138.0000 |  |
500 |
| Frankfurt | 124.4000 | |
338 |
| Düsseldorf | 124.40 | |
133 |
| München | 123.60 | |
100 |
| Hamburg | 123.00 | |
40 |
| Vienna Globa.. | 124.60 | |
0 |
| Hannover | 124.10 | |
0 |
| Berlin | 124.00 | |
0 |
| SIX Swiss Ex.. | 102.00 | |
|
| Lang & Schwa.. | 124.100 | |
|
| gettex | 124.000 | |
|
| EUREX | Options | ||
News
- MOR106 clinical development in atopic dermatitis stopped for futility
10/28/2019 / 21:45 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:02 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:01 - GlobeNewswire - Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
09/13/2018 / 22:04 - GlobeNewswire - Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
09/13/2018 / 22:01 - GlobeNewswire
Real-time